Workshop "Metabonomics: A new tool for exploring biocomplexity"
David MacIntyre
Friday, 01 August 2008 10:10 UTC
Workshop “Metabonomics: A new tool for exploring biocomplexity”
More details on the workshop including registration can be found HERE
Topics
- Fluid Metabonomics
- Tissue and Cell Metabolomics
- Drug Discovery and Toxicity
- Alternative Metabonomics Applications
- Methods and Design
Invited Speakers
Professor Bernardo Celda – Universitat de València (Spain)
Dr. Hector Keun – Imperial College of London (UK)
Dr Sunil Kochhar – Nestlé Research Centre (Switzerland)
Professor Wei Li – University of Tennessee (USA)
Professor John Lindon – Imperial Collego of London (UK)
Professor Claudio Luchinat – Università degli Studi di Firenze (Italy)
Professor José Mª Mato – CIC bio GUNE (Spain)
Dr. Axel Meissner – Leiden University (Holland)
Professor Emmanuel Mikros – University of Athens (Greece)
Dr. Teo Parella – Universidad Autónoma de Barcelona (Spain)
Dr. Antonio Pineda-Lucena – Prince Felipe Research Centre (Spain)
Dr. Katherin Renner – Institute for Functional Genomics (Germany)
Dr. Donald Robertson – Bristol-Myers Squibb Pharmaceuticals (USA)
Dr. Manfred Spraul – Bruker BioSpin (Germany)
In this workshop, an ensemble of international experts will discuss recent developments in the field, describe start of the art applications of metabonomics and examine detailed aspects such as experimental design and appropriate statistical methods for metabonomics.
-
Replies
-
Metabonomics Lecture Series at Roswell Park Cancer Institute, Buffalo, NY, USA
August 21, 2008
Registration is freeTopic: Metabonomic Analysis Using NMR
Invited Speakers
Dr. Jeremy Nicholson
Dr. Elaine Holmes
Dr. John Lindon
Dr. Liz Want
Dr. Hector KeunAll Speakers Affiliated With Imperial College, London, UK
Topic: Platforms in Metabonomics
Invited Speakers
Dr. Jose Castro-Peres (Waters)
Dr. Shawn Ritchie (Phenomenome)
Dr. Jeff Shuster (Metabolon)
Dr. John Hevko (Applied Biosystems)
Dr. Joshua Hicks (Bruker Biospin)The scope of the meeting covers newer advances in metabonomic profiling by NMR and mass spectrometry for the identification of clinical biomarkers. For details contact: Marie Rosati (marie.rosati@RoswellPark.org)
-